NPORT-EX 2 pws.htm Document


Pacer WealthShield ETF
Schedule of Investments
July 31, 2026 (Unaudited)

COMMON STOCKS - 80.4%

Shares  

Value  
Communication Services - 0.1%

AppLovin Corp. - Class A (a)

            56

    $        22,170






Energy - 20.2%

APA Corp.

            778

             29,035
Baker Hughes Co.

            2,191

             132,534
Chevron Corp.

            4,260

             838,496
ConocoPhillips

            2,748

             331,079
Devon Energy Corp.

            2,531

             114,224
Diamondback Energy, Inc.

            427

             86,660
EOG Resources, Inc.

            1,186

             176,346
EQT Corp.

            1,376

             73,327
Expand Energy Corp.

            526

             49,460
ExxonMobil Holdings Corp.

            9,456

             1,469,841
Halliburton Co.

            1,838

             59,275
Kinder Morgan, Inc.

            4,331

             139,371
Marathon Petroleum Corp.

            653

             206,655
Occidental Petroleum Corp.

            1,576

             89,942
ONEOK, Inc.

            1,388

             126,044
Phillips 66

            895

             189,454
SLB Ltd.

            3,324

             164,837
Targa Resources Corp.

            473

             127,885
Texas Pacific Land Corp.

            127

             51,128
Valero Energy Corp.

            664

             207,766
Williams Cos., Inc.

            2,732

             195,447




             4,858,806






Health Care - 18.8%

4D Molecular Therapeutics, Inc. (a)

            747

             7,604
AbbVie, Inc.

            205

             51,443
ABIOMED INC (a)(b)

            64

             0
Absci Corp. (a)

            2,401

             18,680
Acadia Pharmaceuticals, Inc. (a)

            1,841

             47,627
Achieve Life Sciences, Inc. (a)

            627

             4,025
ADMA Biologics, Inc. (a)

            3,607

             30,515
Agios Pharmaceuticals, Inc. (a)

            928

             27,859
Alkermes PLC (a)

            1,052

             51,537
Allogene Therapeutics, Inc. (a)

            5,637

             10,598
Alnylam Pharmaceuticals, Inc. (a)

            158

             32,472
Altimmune, Inc. (a)

            3,759

             10,676
Amgen, Inc.

            137

             52,767
AnaptysBio, Inc. (a)

            365

             19,476
Annexon, Inc. (a)

            2,894

             14,745
Apogee Therapeutics, Inc. (a)

            557

             74,688
Arbutus Biopharma Corp. (a)

            1,706

             7,404
Arcus Biosciences, Inc. (a)

            1,198

             33,772
Arcutis Biotherapeutics, Inc. (a)

            1,349

             36,234
Ardelyx, Inc. (a)

            3,443

             17,043
ArriVent Biopharma, Inc. (a)

            407

             12,137
Arrowhead Pharmaceuticals, Inc. (a)

            652

             55,192
ARS Pharmaceuticals, Inc. (a)

            1,062

             5,448
Avalo Therapeutics, Inc. (a)

            942

             17,192
Beam Therapeutics, Inc. (a)(c)

            1,563

             39,888


Bicara Therapeutics, Inc. (a)

            509

             13,794
BioCryst Pharmaceuticals, Inc. (a)

            4,436

             39,835
Biogen, Inc. (a)(c)

            237

             48,099
Biohaven Ltd. (a)

            1,760

             23,760
BioMarin Pharmaceutical, Inc. (a)

            821

             49,276
BridgeBio Oncology Therapeutics, Inc. (a)

            378

             3,058
Bridgebio Pharma, Inc. (a)

            684

             54,782
Cabaletta Bio, Inc. (a)

            2,440

             6,539
Candel Therapeutics, Inc. (a)

            940

             9,409
Capricor Therapeutics, Inc. (a)

            1,008

             3,881
CareDx, Inc. (a)

            531

             23,210
Celcuity, Inc. (a)

            522

             45,090
Celldex Therapeutics, Inc. (a)

            938

             35,700
CG oncology, Inc. (a)

            839

             59,728
Cogent Biosciences, Inc. (a)

            1,469

             57,188
Compass Therapeutics, Inc. (a)

            3,175

             6,064
Corvus Pharmaceuticals, Inc. (a)

            1,361

             18,047
CRISPR Therapeutics AG (a)

            932

             44,727
Cullinan Therapeutics, Inc. (a)

            1,104

             18,216
Cytokinetics, Inc. (a)

            687

             52,988
CytomX Therapeutics, Inc. (a)

            3,697

             11,461
Damora Therapeutics, Inc. (a)

            332

             9,625
Denali Therapeutics, Inc. (a)

            1,609

             37,039
Dianthus Therapeutics, Inc. (a)(c)

            603

             64,473
Disc Medicine, Inc. (a)

            444

             34,188
Dyne Therapeutics, Inc. (a)

            1,922

             48,396
Emergent BioSolutions, Inc. (a)

            792

             5,718
Erasca, Inc. (a)

            3,448

             62,581
Exelixis, Inc. (a)(c)

            877

             46,507
First Tracks Biotherapeutics, Inc. (a)

            432

             19,025
Geron Corp. (a)

            10,128

             13,065
Gilead Sciences, Inc.

            380

             49,480
GRAIL, Inc. (a)

            660

             45,250
Halozyme Therapeutics, Inc. (a)(c)

            654

             53,981
Hyperliquid Strategies, Inc. (a)

            2,938

             18,245
Ideaya Biosciences, Inc. (a)

            1,071

             38,020
Immix Biopharma, Inc. (a)

            977

             8,129
ImmunityBio, Inc. (a)(c)

            5,786

             41,486
Immunome, Inc. (a)(c)

            1,389

             31,614
Immunovant, Inc. (a)

            1,193

             46,074
Incyte Corp. (a)

            437

             52,230
Inhibrx Biosciences, Inc. (a)

            186

             15,261
Insmed, Inc. (a)

            502

             49,497
Intellia Therapeutics, Inc. (a)

            2,665

             28,462
Ionis Pharmaceuticals, Inc. (a)

            629

             32,563
Iovance Biotherapeutics, Inc. (a)

            6,729

             27,387
Ironwood Pharmaceuticals, Inc. (a)

            2,553

             10,799
Jade Biosciences, Inc. (a)

            712

             14,062
Janux Therapeutics, Inc. (a)

            895

             13,577
Kodiak Sciences, Inc. (a)(c)

            694

             28,857
Krystal Biotech, Inc. (a)

            148

             50,486
Kura Oncology, Inc. (a)

            1,428

             12,866
Kymera Therapeutics, Inc. (a)

            589

             60,903
Lexeo Therapeutics, Inc. (a)

            1,128

             4,659
Madrigal Pharmaceuticals, Inc. (a)

            98

             45,797
MannKind Corp. (a)

            3,954

             15,460
MapLight Therapeutics, Inc. (a)

            231

             3,008
MiMedx Group, Inc. (a)

            1,373

             5,670
Mineralys Therapeutics, Inc. (a)

            1,306

             33,329
Mirum Pharmaceuticals, Inc. (a)

            490

             51,915


Moderna, Inc. (a)(c)

            1,002

             54,930
Monte Rosa Therapeutics, Inc. (a)(c)

            981

             16,206
Myriad Genetics, Inc. (a)

            1,400

             4,004
Natera, Inc. (a)

            213

             57,033
Neurocrine Biosciences, Inc. (a)

            287

             47,872
Novavax, Inc. (a)

            3,486

             25,518
Nurix Therapeutics, Inc. (a)

            1,142

             26,506
Ocugen, Inc. (a)

            6,493

             7,986
Olema Pharmaceuticals, Inc. (a)

            1,261

             14,438
ORIC Pharmaceuticals, Inc. (a)

            1,516

             16,782
Oruka Therapeutics, Inc. (a)(c)

            720

             69,487
Ovid therapeutics, Inc. (a)

            2,284

             5,070
Palvella Therapeutics, Inc. (a)

            190

             26,418
Perspective Therapeutics, Inc. (a)

            1,874

             5,453
Praxis Precision Medicines, Inc. (a)

            192

             59,103
Precigen, Inc. (a)

            3,289

             20,622
Prime Medicine, Inc. (a)

            2,426

             7,084
Protagonist Therapeutics, Inc. (a)

            436

             59,575
Prothena Corp. PLC (a)

            675

             5,481
PTC Therapeutics, Inc. (a)

            629

             42,778
Recursion Pharmaceuticals, Inc. - Class A (a)

            10,248

             30,744
Regeneron Pharmaceuticals, Inc.

            77

             58,723
REGENXBIO, Inc. (a)

            909

             8,808
Relay Therapeutics, Inc. (a)

            2,919

             54,965
Replimune Group, Inc. (a)

            1,275

             14,280
Revolution Medicines, Inc. (a)

            320

             60,010
Rhythm Pharmaceuticals, Inc. (a)

            538

             53,397
Rigel Pharmaceuticals, Inc. (a)(c)

            302

             11,117
Roivant Sciences Ltd. (a)(c)

            1,623

             55,036
Sagimet Biosciences, Inc. - Class A (a)

            456

             3,242
Sana Biotechnology, Inc. (a)

            3,286

             10,285
Sarepta Therapeutics, Inc. (a)(c)

            2,065

             30,686
Savara, Inc. (a)

            1,484

             8,103
Scholar Rock Holding Corp. (a)

            1,046

             49,471
SELLAS Life Sciences Group, Inc. (a)(c)

            4,006

             40,100
Sionna Therapeutics, Inc. (a)

            301

             14,186
Solid Biosciences, Inc. (a)

            1,199

             9,664
Spyre Therapeutics, Inc. (a)

            614

             60,375
Stoke Therapeutics, Inc. (a)

            731

             21,097
Summit Therapeutics, Inc. (a)

            3,451

             44,932
Syndax Pharmaceuticals, Inc. (a)

            1,633

             31,109
Tango Therapeutics, Inc. (a)

            1,338

             36,367
Taysha Gene Therapies, Inc. (a)

            2,584

             15,142
TG Therapeutics, Inc. (a)

            989

             51,458
Travere Therapeutics, Inc. (a)

            986

             55,108
Twist Bioscience Corp. (a)

            680

             62,254
Tyra Biosciences, Inc. (a)

            646

             20,594
Ultragenyx Pharmaceutical, Inc. (a)

            1,698

             42,297
uniQure NV (a)

            1,110

             48,429
United Therapeutics Corp. (a)

            85

             44,005
Vanda Pharmaceuticals, Inc. (a)

            1,064

             5,426
Vaxcyte, Inc. (a)

            1,015

             54,891
Vera Therapeutics, Inc. (a)

            1,227

             39,387
Veracyte, Inc. (a)

            693

             32,100
Verastem, Inc. (a)

            1,573

             9,123
Vericel Corp. (a)

            554

             25,462
Vertex Pharmaceuticals, Inc. (a)

            106

             50,573
Viking Therapeutics, Inc. (a)

            1,661

             52,720
Vir Biotechnology, Inc. (a)

            2,296

             19,883
Viridian Therapeutics, Inc. (a)

            1,816

             34,359


Vor BioPharma, Inc. (a)

            815

             17,237
Xencor, Inc. (a)

            901

             18,209
Zenas Biopharma, Inc. (a)

            626

             19,681




             4,530,939






Industrials - 20.1%

3M Co.

            452

             79,679
A O Smith Corp. (c)

            97

             5,833
Allegion PLC

            74

             11,648
AMETEK, Inc.

            199

             48,100
Automatic Data Processing, Inc.

            346

             92,195
Axon Enterprise, Inc. (a)

            70

             36,943
Boeing Co. (a)

            683

             147,624
Broadridge Financial Solutions, Inc.

            100

             15,395
Builders FirstSource, Inc. (a)

            93

             6,179
Carrier Global Corp.

            676

             41,784
Caterpillar, Inc. (c)

            399

             325,109
CH Robinson Worldwide, Inc. (c)

            102

             15,068
Cintas Corp.

            295

             60,366
Comfort Systems USA, Inc.

            30

             51,891
Copart, Inc. (a)(c)

            768

             22,364
CSX Corp.

            1,609

             81,094
Cummins, Inc.

            120

             76,104
Deere & Co. (c)

            218

             129,202
Delta Air Lines, Inc.

            566

             49,491
Dover Corp.

            117

             23,941
Eaton Corp. PLC (c)

            336

             139,507
EMCOR Group, Inc.

            38

             30,302
Emerson Electric Co.

            485

             72,663
Equifax, Inc.

            103

             17,780
Expeditors International of Washington, Inc.

            113

             18,972
Fastenal Co.

            994

             47,424
FedEx Corp.

            190

             58,406
Fedex Freight Holding Co., Inc. (a)

            94

             13,210
Fortive Corp.

            264

             15,631
GE Vernova, Inc.

            233

             230,738
Generac Holdings, Inc. (a)

            51

             10,053
General Dynamics Corp.

            220

             84,352
General Electric Co.

            904

             325,503
Honeywell Aerospace, Inc. (a)

            274

             56,647
Honeywell International, Inc.

            274

             66,596
Howmet Aerospace, Inc.

            347

             97,944
Hubbell, Inc.

            46

             21,737
Huntington Ingalls Industries, Inc.

            34

             11,099
IDEX Corp.

            64

             14,749
Illinois Tool Works, Inc.

            227

             65,138
Ingersoll Rand, Inc.

            308

             25,681
Jacobs Solutions, Inc.

            102

             13,763
JB Hunt Trasport Services, Inc.

            65

             17,664
Johnson Controls International PLC (c)

            528

             77,436
L3Harris Technologies, Inc.

            161

             44,607
Leidos Holdings, Inc.

            109

             12,600
Lennox International, Inc.

            27

             11,229
Lockheed Martin Corp. (c)

            176

             102,562
Masco Corp.

            175

             12,509
Nordson Corp.

            46

             13,698
Norfolk Southern Corp.

            195

             65,419
Northrop Grumman Corp.

            116

             62,928
Old Dominion Freight Line, Inc.

            159

             33,730


Otis Worldwide Corp.

            332

             23,887
PACCAR, Inc.

            456

             60,502
Parker-Hannifin Corp.

            109

             106,442
Paychex, Inc.

            279

             32,598
Pentair PLC

            140

             9,162
Quanta Services, Inc.

            130

             86,757
Republic Services, Inc.

            173

             36,425
Rockwell Automation, Inc.

            96

             46,088
Rollins, Inc.

            254

             9,644
RTX Corp.

            1,166

             250,946
Snap-On, Inc.

            45

             18,468
Southwest Airlines Co. (c)

            423

             19,022
Stanley Black & Decker, Inc. (c)

            135

             12,768
Textron, Inc. (c)

            151

             12,874
Trane Technologies PLC

            191

             86,895
TransDigm Group, Inc.

            48

             60,210
Uber Technologies, Inc. (a)

            1,763

             124,045
Union Pacific Corp.

            514

             150,155
United Airlines Holdings, Inc. (a)

            281

             34,094
United Parcel Service, Inc. - Class B

            647

             67,430
United Rentals, Inc. (c)

            54

             58,280
Veralto Corp.

            213

             20,058
Verisk Analytics, Inc.

            113

             22,018
Vertiv Holdings Co. - Class A

            333

             80,443
W.W. Grainger, Inc.

            38

             52,524
Waste Management, Inc.

            320

             72,496
Westinghouse Air Brake Technologies Corp.

            147

             42,756
Xylem, Inc.

            206

             24,096




             4,833,370






Information Technology - 20.3%

Accenture PLC - Class A

            127

             21,072
Adobe, Inc. (a)

            84

             21,034
Advanced Micro Devices, Inc. (a)

            339

             161,415
Akamai Technologies, Inc. (a)

            30

             3,455
Amphenol Corp.

            255

             40,979
Analog Devices, Inc. (c)

            101

             37,108
Apple, Inc.

            3,045

             940,631
Applied Materials, Inc.

            165

             83,766
Arista Networks, Inc. (a)

            214

             38,595
Autodesk, Inc. (a)

            44

             10,305
Broadcom, Inc.

            983

             382,662
Cadence Design System, Inc. (a)

            57

             19,381
CDW Corp. (c)

            27

             3,991
Ciena Corp. (a)

            29

             10,934
Cisco Systems, Inc.

            820

             95,112
Cognizant Technology Solutions Corp.

            98

             5,424
Coherent Corp. (a)

            41

             10,779
Corning, Inc.

            163

             22,535
Crowdstrike Holdings, Inc. - Class A (a)

            212

             40,462
Datadog, Inc. - Class A (a)

            69

             18,490
Dell Technologies, Inc. - Class C

            60

             24,322
F5, Inc. (a)

            12

             4,831
Fair Isaac Corp. (a)

            5

             5,615
First Solar, Inc. (a)

            22

             4,643
Flex Ltd. (a)

            76

             8,645
Fortinet, Inc. (a)

            129

             20,892
Gartner, Inc. (a)

            14

             2,114
Gen Digital, Inc.

            114

             3,129


GoDaddy, Inc. - Class A (a)

            27

             2,234
Hewlett Packard Enterprise Co.

            275

             13,173
HP, Inc.

            190

             5,181
Intel Corp. (a)

            981

             88,486
International Business Machines Corp.

            195

             43,612
Intuit, Inc.

            57

             18,016
Jabil, Inc.

            22

             6,931
Keysight Technologies, Inc. (a)

            36

             11,487
KLA Corp.

            271

             49,544
Lam Research Corp.

            260

             76,185
Lumentum Holdings, Inc. (a)

            16

             11,423
Marvell Technology, Inc.

            182

             34,136
Microchip Technology, Inc.

            112

             8,321
Micron Technology, Inc.

            234

             192,589
Microsoft Corp.

            1,542

             716,598
Monolithic Power Systems, Inc.

            10

             14,260
Motorola Solutions, Inc.

            34

             14,816
NetApp, Inc.

            41

             7,319
NVIDIA Corp.

            5,021

             1,007,966
NXP Semiconductors NV

            52

             11,916
ON Semiconductor Corp. (a)

            81

             6,610
Oracle Corp.

            352

             45,714
Palantir Technologies, Inc. - Class A (a)

            477

             58,700
Palo Alto Networks, Inc. (a)

            168

             55,747
PTC, Inc. (a)

            24

             3,293
Qnity Electronics, Inc.

            43

             5,641
QUALCOMM, Inc.

            219

             32,327
Roper Technologies, Inc.

            21

             8,231
salesforce.com, Inc.

            170

             31,283
Sandisk Corp. (a)

            31

             37,660
Seagate Technology Holdings PLC

            47

             40,238
ServiceNow, Inc. (a)

            214

             23,803
Skyworks Solutions, Inc. (c)

            31

             1,931
Super Micro Computer, Inc. (a)(c)

            117

             3,323
Synopsys, Inc. (a)

            40

             15,550
TE Connectivity PLC

            61

             12,547
Teledyne Technologies, Inc. (a)

            10

             6,556
Teradyne, Inc.

            33

             12,134
Texas Instruments, Inc.

            189

             52,115
Trimble, Inc. (a)(c)

            48

             2,716
Tyler Technologies, Inc. (a)

            9

             2,786
VeriSign, Inc.

            17

             4,930
Western Digital Corp.

            72

             39,228
Workday, Inc. - Class A (a)

            42

             6,734
Zebra Technologies Corp. (a)

            10

             2,938




             4,889,249






Real Estate - 0.9%

CBRE Group, Inc. - Class A (a)

            1,178

             172,942
CoStar Group, Inc. (a)

            1,642

             47,224




             220,166
TOTAL COMMON STOCKS (Cost $19,229,742)

             19,354,700






REAL ESTATE INVESTMENT TRUSTS - 19.3%

Shares  

Value  
Real Estate - 19.3%

Alexandria Real Estate Equities, Inc.

            631

             32,465
American Tower Corp.

            1,874

             324,877
AvalonBay Communities, Inc.

            559

             103,756
BXP, Inc.

            596

             41,792


Camden Property Trust

            404

             44,767
Crown Castle, Inc.

            1,755

             133,906
Digital Realty Trust, Inc.

            1,392

             262,420
Equinix, Inc.

            396

             403,635
Equity Residential

            1,371

             91,103
Essex Property Trust, Inc.

            258

             73,308
Extra Space Storage, Inc.

            850

             125,834
Federal Realty Investment Trust

            316

             39,212
Healthpeak Properties, Inc.

            2,773

             60,535
Host Hotels & Resorts, Inc.

            2,562

             64,383
Invitation Homes, Inc.

            2,198

             65,325
Iron Mountain, Inc.

            1,197

             146,417
Kimco Realty Corp.

            2,712

             69,102
Mid-America Apartment Communities, Inc.

            468

             61,935
Prologis, Inc. (c)

            3,739

             540,697
Public Storage

            670

             217,194
Realty Income Corp.

            3,750

             239,513
Regency Centers Corp.

            663

             53,232
SBA Communications Corp.

            427

             77,278
Simon Property Group, Inc.

            1,304

             299,098
UDR, Inc.

            1,189

             45,372
Ventas, Inc. (c)

            1,955

             182,812
VICI Properties, Inc.

            4,395

             115,808
Welltower, Inc.

            2,829

             663,231
Weyerhaeuser Co.

            2,900

             72,587
TOTAL REAL ESTATE INVESTMENT TRUSTS (Cost $4,550,309)

             4,651,594






RIGHTS - 0.0% (d)

Shares  

Value  
Health Care - 0.0% (d)

Pfizer, Inc., Expires 11/16/2026, Exercise Price $20.65 (a)(b)

            1,297

             6,356
Roche Holding AG, Expires 10/28/2026, Exercise Price $1.00 (a)(b)

            2,242

             762
TOTAL RIGHTS (Cost $0)

             7,118






SHORT-TERM INVESTMENTS
INVESTMENTS PURCHASED WITH PROCEEDS FROM SECURITIES LENDING - 9.0%
Units  

Value  
Mount Vernon Liquid Assets Portfolio, LLC, 3.79% (e)

            2,157,324

             2,157,324
TOTAL INVESTMENTS PURCHASED WITH PROCEEDS FROM SECURITIES LENDING (Cost $2,157,324)

             2,157,324






TOTAL INVESTMENTS - 108.7% (Cost $25,937,375)

             26,170,736
Liabilities in Excess of Other Assets - (8.7)%
(0.08744)
            (2,104,370)
TOTAL NET ASSETS - 100.0%




    $        24,066,366


Percentages are stated as a percent of net assets.



The Global Industry Classification Standard (“GICS®”) was developed by and/or is the exclusive property of MSCI, Inc. (“MSCI”) and Standard & Poor’s Financial Services LLC (“S&P”). GICS® is a service mark of MSCI and S&P and has been licensed for use by U.S. Bank Global Fund Services.



(a)

Non-income producing security.
(b)

Fair value determined using significant unobservable inputs in accordance with procedures established by and under the supervision of the Adviser, acting as Valuation Designee. These securities represented $7,117 or 0.0% of net assets as of July 31, 2026.
(c)

All or a portion of this security is on loan as of July 31, 2026. The fair value of these securities was $2,095,492.
(d)

Represents less than 0.05% of net assets.
(e)

The rate shown represents the 7-day annualized yield as of July 31, 2026.



Summary of Fair Value Disclosure as of July 31, 2026 (Unaudited)

Pacer WealthShield ETF has adopted fair value accounting standards which establish a definition of fair value and set out a hierarchy for measuring fair value. These standards require additional disclosures about the various inputs and valuation techniques used to develop the measurements of fair value, a discussion of changes in valuation techniques and related inputs during the period, and expanded disclosure of valuation levels for major security types. These inputs are summarized in the three broad levels listed below. The inputs or valuation methodology used for valuing securities are not an indication of the risk associated with investing in those securities.
Level 1 - Unadjusted quoted prices in active markets for identical assets or liabilities that the Fund has the ability to access.
Level 2 - Observable inputs other than quoted prices included in Level 1 that are observable for the asset or liability, either directly or indirectly. These inputs may include quoted prices for the identical instrument on an inactive market, prices for similar instruments, interest rates, prepayment speeds, credit risk, yield curves, default rates and similar data.
Level 3 - Unobservable inputs for the asset or liability, to the extent relevant observable inputs are not available, representing the Fund’s own assumptions about the assumptions a market participant would use in valuing the asset or liability, and based on the best information available.
The following is a summary of the fair valuation hierarchy of the Fund’s securities as of July 31, 2026:



Level 1

Level 2

Level 3

Total
Investments:







  Common Stocks
    $        19,354,700

    $        –

    $        0

    $        19,354,700
  Real Estate Investment Trusts
            4,651,594

            –

            –

            4,651,594
  Rights
            –

            –

            7,118

            7,118
  Investments Purchased with Proceeds from Securities Lending (a)
            –

            –

            –

            2,157,324
Total Investments
    $        24,006,294

    $        –

    $        7,118

    $        26,170,736



 

Refer to the Schedule of Investments for further disaggregation of investment categories.
(a)

Certain investments that are measured at fair value using the net asset value per share (or its equivalent) practical expedient have not been categorized in the fair value hierarchy. The fair value amount presented in the table is intended to permit reconciliation of the fair value hierarchy to the amounts listed in the Schedule of Investments.



Fair Value Measurement Using Significant Unobservable Inputs

Level 3
Beginning balance as of April 30, 2026

    $        7,118
Purchases

             141,391
Sales

             (130,502)
Realized gain/loss

             (10,889)
Ending balance as of July 31, 2026

    $        7,118


$0
Change in unrealized appreciation/depreciation still held as of July 31, 2026

    $        0


 0





Description

Fair Value as of July 31, 2026

Valuation Technique

Unobservable Inputs

Input Values (Ranges)
Common Stocks

    $        0

Acquisition Price

Stale Data

    $        –
Rights

             7,118

Intrinsic Value

Corporate Action

             –


    $        7,118